NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PrintBio, Inc.

PrintBio, Inc.

Private
Surfside, FloridaHealthcare & Life Scienceshttps://printbio.com/

Last Round

Grant

Feb 12, 2026

Total Funding Raised

$8.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PrintBio, Inc. is a biotechnology company that develops 3D-bioprinting technology and material science solutions for regenerative medicine, including living tissue implants and programmable surgical meshes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

3D bioprintingregenerative medicineliving tissue implantssurgical meshbio-inkbioprintingtissue engineeringbioresorbable materialspersonalized medicinemedical 3D printingbiotech manufacturingreconstructive surgerybioprinted organscurrent good manufacturing practicecGMPbiofabrication

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrintBio, Inc. Comparables

Compare PrintBio, Inc. with similar companies based on industry and business-model similarity.

PrintBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3D Systems
77%
CollPlant Biotechnologies Ltd.
70%
ROKIT Healthcare
67%

PrintBio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 12, 2026
Corporate FundingFeb 29, 2024
Series AApr 10, 2019

Key People

Founding team and executive leadership

Kevin Slawin

Chairman, Founder and CEO

Founding Team

PrintBio, Inc. Investors

Notable investors and investment history

PrintBio, Inc. investors
InvestorRounds
Rapha Capital ManagementCorporate Funding, Series A
ARPA-HGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 1085% MoM, reaching 5.9K.

PrintBio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PrintBio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PrintBio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSurfside, Florida
Employee Range7
Year Founded2024
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.